Transforming Companion Animal Health


Poïesis Therapeutics is a biotechnology start-up focused on sourcing and in-licensing innovative late stage therapeutics and diagnostics from human biomedical research and developing them to address unmet needs in the veterinary market for companion animals – horses, dogs and cats.


One World.
One Medicine.
One Health.


Our mission statement adheres to the “one health” concept, reflective of the inherent synergies between animal and human medicine.



Developing new medicines to address unmet needs in animal health.


Developing new veterinary diagnostics to identify disorders in dogs, cats and horses.

Corporate Social Responsibility

Poïesis contributes a percentage of its profits to chosen charities which are making a difference for humans and animals.

Latest News

Poïesis Opens Seed Round Seeking $5 Million

Following on its move from London to San Diego, California, Poïesis has opened its Seed Round of financing seeking to raise $5 million to complete in-licensing and initiate clinical development of its therapeutic and diagnostic pipeline in several indications in dogs,...

read more

Three Trends That Will Transform Animal Health

By Michael Helmstetter, Ph.D., President and CEO, TechAccel, July 27, 2017.  Many investors who are interested in the animal health space still feel they don’t know the industry well enough to make smart investments. The feeling is understandable. Animal health is an...

read more

Why Pet Health Is The Focus Of A New Biotech Sector

By Cathy Yarbrough, Contributing Editor   For Aratana Therapeutics, 2016 was a banner year. The biotech company, founded in 2010, achieved FDA approvals for three of its 10 pipeline drugs. Last year the Kansas City-based company also forged a global partnership with...

read more

A Tale of Two Acquisitions

By Joseph Harvey, 20 April 2017. So far, 2017 has said farewell to Merial and seen the purchase of Nexvet Biopharma – two very different companies in the animal health space. Animal Pharm editor Joseph Harvey takes a closer look at these two transactions and their...

read more

Pet Meds Adapted from Human Therapies

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market. By Jenny Rood | October 1, 2016. Around Christmas 2010, University of Minnesota researcher Mark Suckow received terrible news:...

read more